dr. J.F.M. (Job) van Boven

Assistant Professor

dr. J.F.M. (Job) van Boven
Telephone:
E-mail:
j.f.m.van.boven rug.nl

Research

CV

Profile photodr. Job FM van Boven
Assistant Professor
1. Department of Clinical Pharmacy & Pharmacology
2. Department of General Practice, Groningen Research Institute for Asthma and COPD (GRIAC)
University Medical Center Groningen, University of Groningen

Postal address:
University Medical Center Groningen
Dept of Clin Pharmacy & Pharmacology
PO Box 30001, EB70
Groningen
The Netherlands
Email: J.F.M.van.Boven@umcg.nl
Tel: +31 50 361 7893
Fax: +31 50 363 2964

Research interests

Medication adherence, real-world drug outcomes, health economics, cost-effectiveness, burden of diseases, respiratory diseases (asthma, COPD, TB, lung cancer)

Research output

A personalised screening strategy for diabetic retinopathy: a cost-effectiveness perspective

Emamipour, S., van der Heijden, A. A. W. A., Nijpels, G., Elders, P. J. M., Beulens, J. W. J., Postma, M., Boven, van, J. & Feenstra, T. L., 31-Jul-2020, In : Diabetologia. 10 p.

‘Frisse’ berglucht toch niet altijd gezond?

Brakema, E., Kasteleyn, M., Molendijk, E., Tabyshova, A., van der Kleij, R., van Boven, J. F. M., Numans, M. E., Chavannes, N. H., Emilov, B., Akmatalieva, M., Mademilov, M., Sooronbaev, T. & Williams, S., 29-Jun-2020, In : Huisarts en Wetenschap. 63, p. 1-7 7 p.

Prevalence and Attributable Health Burden of Chronic Respiratory Diseases, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017

GBD Chronic Respiratory Disease Collaborators & Boven, van, J., 5-Jun-2020, In : The Lancet. Respiratory Medicine. 8, 6, p. 585-596 12 p.

Prevalence of Seasonal Influenza Vaccination in Chronic Obstructive Pulmonary Disease (COPD) Patients in the Balearic Islands (Spain) and Its Effect on COPD Exacerbations: A Population-Based Retrospective Cohort Study

Ruiz Azcona, L., Roman-Rodriguez, M., Llort Bove, M., van Boven, J. F. & Santibáñez Margüello, M., 5-Jun-2020, In : International Journal of Environmental Research and Public Health. 17, 11, 12 p., 4027.

Interventions to improve medication adherence in tuberculosis patients: A systematic review of randomized controlled studies

Pradipta, I. S., Houtsma, D., van Boven, J. F. M., Alffenaar, J-W. C. & Hak, E., 11-May-2020, In : npj Primary Care Respiratory Medicine. 30, 1, 10 p., 21.

Spacers and Valved Holding Chambers—The Risk of Switching to Different Chambers

Lavorini, F., Barreto, C., van Boven, J. F. M., Carroll, W., Conway, J., Costello, R. W., Dahl, B. H., Dekhuijzen, R. P. N., Holmes, S., Levy, M., Molimard, M., Roche, N., Román-Rodriguez, M., Scichilone, N., Scullion, J. & Usmani, O. S., May-2020, In : Journal of Allergy and Clinical Immunology: In Practice. 8, 5, 5 p.

Health Sector Spending and Spending on HIV/AIDS, Tuberculosis, and Malaria, and Development Assistance for Health: Progress Towards Sustainable Development Goal 3

Global Burden of Disease Collaborators & Boven, van, J., 23-Apr-2020, In : The Lancet. 32 p.

Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial

Duiverman, M. L., Vonk, J. M., Bladder, G., van Melle, J. P., Nieuwenhuis, J., Hazenberg, A., Kerstjens, H. A. M., van Boven, J. F. M. & Wijkstra, P. J., 31-Mar-2020, In : Thorax. 75, 3, p. 244-252 9 p.

User Acceptability and Technical Robustness Evaluation of a Novel Smart Pill Bottle Prototype Designed to Support Medication Adherence

Zijp, T. R., Touw, D. J. & Boven, van, J. F. M., 20-Mar-2020, In : Patient Preference and Adherence. 14, p. 625-634 10 p.

Trajectory analyses of adherence patterns in a real-life moderate to severe asthma population

van Boven, J. F. M., Koponen, M., Lalic, S., George, J., Bell, J. S., Hew, M. & Ilomaki, J., 15-Mar-2020, (Accepted/In press) In : Journal of Allergy and Clinical Immunology: In Practice. 15 p.

Discrepantie tussen indicatie en aflevering van aerosolen

Boven, van, J. & Kooistra, J., 7-Mar-2020, In : Pharmaceutisch Weekblad. 155, 10, p. 36-37 2 p.

Goed volgen nieuwe COPD-richtlijn maakt kostenbesparing mogelijk

van der Pol, S., Fens, T., Kocks, J. W. H., Postma, M. & Boven, van, J., 6-Mar-2020, In : Pharmaceutisch Weekblad. 155, 10, p. 26-27 2 p.

Influence of age on real-life effects of doxycycline for acute exacerbations among COPD outpatients: a population-based cohort study

Wang, Y., Bos, J., Boezen, H. M., Alffenaar, J-W., Boven, van, J., Schuiling-Veninga, C., Wilffert, B. & Hak, E., Feb-2020, In : BMJ Open Respir Res. 7, 1, 10 p., e000535.

Let’s stop dumping cookstoves in local communities. It’s time to get implementation right

FRESH AIR Collaborators, Brakema, E. A., van der Kleij, R. M., Vermond, D., van Gemert, F. A. & Kirenga, B., 10-Jan-2020, In : npj Primary Care Respiratory Medicine. 30, 1, 3 p., 3.

Benefits and harm of systemic steroids for short- And long-term use in rhinitis and rhinosinusitis: An EAACI position paper

Hox, V., Lourijsen, E., Jordens, A., Aasbjerg, K., Agache, I., Alobid, I., Bachert, C., Boussery, K., Campo, P., Fokkens, W., Hellings, P., Hopkins, C., Klimek, L., Mäkelä, M., Mösges, R., Mullol, J., Pujols, L., Rondon, C., Rudenko, M., Toppila-Salmi, S., Scadding, G., Scheire, S., Tomazic, P-V., Van Zele, T., Wagemann, M., Van Boven, J. F. M. & Gevaert, P., 3-Jan-2020, In : Clinical and translational allergy. 10, 1, 27 p., 1.

Targeted and tailored pharmacist-led intervention to improve adherence to antihypertensive drugs among patients with type 2 diabetes in Indonesia: Study protocol of a cluster randomised controlled trial

Alfian, S. D., Abdulah, R., Denig, P., van Boven, J. F. M. & Hak, E., Jan-2020, In : BMJ Open. 10, 1, 8 p., e034507.

The socioeconomic burden of chronic lung disease in low-resource settings across the globe - an observational FRESH AIR study

FRESH AIR Collaborators, Brakema, E. A., Tabyshova, A., van der Kleij, R. M. J. J., Sooronbaev, T., Lionis, C., Anastasaki, M., Pham Le An, T., Luan Than Nguyen, Kirenga, B., Walusimbi, S., Postma, M. J., Chavannes, N. H. & van Boven, J. F. M., 21-Dec-2019, In : Respiratory Research. 20, 1, 10 p., 291.

PDB34 A PERSONALIZED SCREENING STRATEGY FOR DIABETIC RETINOPATHY: A COST-EFFECTIVENESS PERSPECTIVE

Emamipour, S., van der Heijden, A. A. W. A., Postma, M., van Boven, J. F. M. & Feenstra, T., 1-Nov-2019, In : Value in Health. 22, p. 578 1 p.

Mapping 123 million neonatal, infant and child deaths between 2000 and 2017

Global Burden of Disease Collaborators, Burstein, R., Henry, N. J., Collison, M. L., Marczak, L. B., Sligar, A., Watson, S., Marquez, N., Abbasalizad-Farhangi, M., Abbasi, M., Abd-Allah, F., Abdoli, A., Abdollahi, M., Abdollahpour, I., Abdulkader, R. S., Abrigo, M. R. M., Acharya, D., Adebayo, O. M., Adekanmbi, V., Adham, D., Afshari, M., Aghaali, M., Ahmadi, K., Ahmadi, M., Ahmadpour, E., Ahmed, R., Akal, C. G., Akinyemi, J. O., Alahdab, F., Alam, N., Alamene, G. M., Alene, K. A., Alijanzadeh, M., Alinia, C., Alipour, V., Aljunid, S. M., Almalki, M. J., Al-Mekhlafi, H. M., Altirkawi, K., Alvis-Guzman, N., Amegah, A. K., Amini, S., Amit, A. M. L., Anbari, Z., Androudi, S., Anjomshoa, M., Fischer, F., Shushtari, Z. J., Khan, M. S., Shuval, K. & van Boven, J. F. M., 18-Oct-2019, In : Nature. 574, 7778, p. 353-358 6 p.

Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease: ISPOR’s guidance on budget impact in practice

Fens, T., van der Pol, S., Kocks, J. W. H., Postma, M. J. & van Boven, J. F. M., Oct-2019, In : Value in Health. 22, 10, p. 1092-1101 10 p.

Real-life effectiveness of inhaler device switch from dry powder inhalers to pressurized metred-dose inhalers in patients with asthma treated with ICS/LABA

Park, H-S., Yoon, D., Lee, H. Y., Ban, G-Y., Wan Yau Ming, S., Jie, J. L. Z., Carter, V., Hardjojo, A., Van Boven, J. F. M. & Price, D. B., Oct-2019, In : Respirology. 24, 10, p. 972-979 8 p.

Smart Medication Adherence Monitoring in Clinical Drug Trials: A Prerequisite for Personalised Medicine?

Zijp, T. R., Mol, P. G. M., Touw, D. J. & van Boven, J. F. M., Oct-2019, In : EClinicalMedicine. 15, p. 3-4 2 p.

De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care

de Jong, C., Van Boven, J., Schermer, T., Riemersma, R., Brill, E., Van Den Berge, M., Van Der Molen, T. & Kocks, J., 28-Sep-2019, In : European Respiratory Journal. 54, 3 p.

Effectiveness and acceptability of a smart inhaler asthma self-management programme: a cluster RCT study protocol

van de Hei, S. J., Poot, C. C., Meijer, E., Metting, E. I., Postma, M. J., Van Boven, J. F. M., Chavannes, N. H. & Kocks, J. W. H., 28-Sep-2019, In : European Respiratory Journal. 54, 3 p.

Effects of implementing improved cookstoves and heaters to reduce household air pollution: a FRESH AIR study

van Gemert, F., De Jong, C., Kirenga, B., Musinguzi, P., Buteme, S., Sooronbaev, T., Tabyshova, A., Emilov, B., Mademilov, M., An Pham Le, T., Quynh Nguyen Nhat, Dang Tran Ngoc, Hong Le Huynh Thi Cam, Chartier, R. & Van Boven, J., 28-Sep-2019, In : European Respiratory Journal. 54, 3 p.

Eosinophil distribution and description in a population cohort of asthmatic patients

Pons, N. T., Van Boven, J. F., Roman-Rodriguez, M., Milian, A., Kocks, J. W. H., Soriano, J. B. & Cosio, B. G., 28-Sep-2019, In : European Respiratory Journal. 54, 2 p.

Home initiation of chronic high-intensity noninvasive ventilation in COPD patients with chronic hypercapnic respiratory failure: the RECONSIDER trial

Duiverman, M. L., Bladder, G., Vonk, J. M., Van Boven, J. F. M., Nieuwenhuis, J., Hazenberg, A., Kerstjens, H. A. M. & Wijkstra, P. J., 28-Sep-2019, In : European Respiratory Journal. 54, 2 p.

Groningen pakt therapietrouw aan met multidisciplinair centrum: Apothekers, artsen en andere zorgverleners werken aan goed medicijngebruik

Boven, van, J., Stevens, J., Brand, P. & Dijk, van, L., 13-Sep-2019, In : Pharmaceutisch Weekblad. 154, 37, p. 10-12 3 p.

Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review

van Schoonhoven, A. V., Gout-Zwart, J. J., de Vries, M. J. S., van Asselt, A. D. I., Dvortsin, E., Vemer, P., van Boven, J. F. M. & Postma, M. J., 6-Sep-2019, In : PLoS ONE. 14, 9, 22 p., e0221856.

Prevalence and Characteristics of Asthma-COPD Overlap in Routine Primary Care Practices

Krishnan, J. A., Nibber, A., Chisholm, A., Price, D., Bateman, E. D., Bjermer, L., van Boven, J. F., Brusselle, G., Costello, R. W., Dandurand, R. J., Diamant, Z., Van Ganse, E., Gouder, C., van Kampen, S. C., Kaplan, A., Kocks, J., Miravitlles, M., Niimi, A., Pizzichini, E., Rhee, C. K., Soriano, J. B., Vogelmeier, C., Román-Rodriguez, M., Carter, V. & Roche, N., Sep-2019, In : Annals of the American Thoracic Society. 16, 9, p. 1143-1150 8 p.

Effects and acceptability of implementing improved cookstoves and heaters to reduce household air pollution: a FRESH AIR study

FRESH AIR Collaborators, van Gemert, F., de Jong, C., Kirenga, B., Musinguzi, P., Buteme, S., Sooronbaev, T., Tabyshova, A., Emilov, B., Mademilov, M., Le An, P., Quynh, N. N., Dang, T. N., Hong, L. H. T. C., Chartier, R., Brakema, E. A. & van Boven, J. F. M., 15-Aug-2019, In : npj Primary Care Respiratory Medicine. 29, 1, 9 p., 32.

Voorzetkamers zijn niet een-op-een uitwisselbaar

Dekhuijzen, P. N. R., van Aalderen, W. M. C., Kievits, R. M. M., Kooistra, J., Hagedoorn, P. & Boven, van, J., 15-Aug-2019, In : Nederlands tijdschrift voor allergie & astma. 19, 3, p. 90-94 5 p.

Costs of case-finding uncovered: time to revisit COPD's value pyramid?

van Boven, J. F. M., Aug-2019, In : Thorax. 74, 8, p. 727-729 3 p.

Diabetes mellitus comorbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review

Lutfiana, N. C., van Boven, J. F. M., Zubair, M. A. M., Pena, M. J. & Alffenaar, J-W. C., Jul-2019, In : British Journal of Clinical Pharmacology. 85, 7, p. 1407-1417 11 p.

The Hidden Story of Nonadherence with Asthma Therapy: For a Few Dollars More?

van Boven, J. F. M. & Chapman, K. R., 21-Jun-2019, In : Journal of Allergy and Clinical Immunology: In Practice. 7, 7, p. 2307-2308 2 p.

Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050

Global Burden Dis Hlth Financing C, 1-Jun-2019, In : The Lancet. 393, 10187, p. 2233-2260 28 p.

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients

GLIMP Investigators, Di Pasquale, M. F., Sotgiu, G., Gramegna, A., Radovanovic, D., Terraneo, S., Reyes, L. F., Rupp, J., del Castillo, J. G., Blasi, F., Aliberti, S. & Restrepo, M. I., 1-May-2019, In : Clinical Infectious Diseases. 68, 9, p. 1482-1493 12 p.

COPD's early origins in low-and-middle income countries: what are the implications of a false start?

FRESH AIR Collaborators, Brakema, E. A., van Gemert, F. A., van der Kleij, R. M. J. J., Salvi, S., Puhan, M. & Chavannes, N. H., 5-Mar-2019, In : npj Primary Care Respiratory Medicine. 29, 3 p., 6.

Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation

Rhee, C. K., van Boven, J. F. M., Yau Ming, S. W., Park, H. Y., Kim, D. K., Park, H-S., Zhi Jie, J. L., Yoo, K-H. & Price, D. B., 1-Mar-2019, In : Journal of Allergy and Clinical Immunology: In Practice. 7, 3, p. 934-942 9 p.

Making sense of cost-effectiveness analyses in respiratory medicine: a practical guide for non-health economists

van Boven, J. F. M., van de Hei, S. J. & Sadatsafavi, M., 1-Mar-2019, In : European Respiratory Journal. 53, 3, 11 p., 1801816.

An international perspective on hospitalized patients with viral community-acquired pneumonia

GLIMP Study Group, Radovanovic, D., Sotgiu, G., Jankovic, M., Mahesh, P. A., Marcos, P. J., Abdalla, M. I., Di Pasquale, M. F., Gramegna, A., Terraneo, S., Blasi, F., Santus, P., Aliberti, S., Reyes, L. F., Restrepo, M. I., Aruj, P. K., Attorri, S., Barimboim, E., Caeiro, J. P., Garzón, M. I., Cambursano, V. H., Ceccato, A., Chertcoff, J., Cordon Díaz, A., de Vedia, L., Ganaha, M. C., Lambert, S., Lopardo, G., Luna, C. M., Malberti, A. G., Morcillo, N., Tartara, S., Pensotti, C., Pereyra, B., Scapellato, P. G., Stagnaro, J. P., Shah, S., Lötsch, F., Thalhammer, F., Anseeuw, K., Francois, C. A., Van Braeckel, E., Vincent, J. L., Djimon, M. Z., Aranha Nouér, S., Chipev, P., Encheva, M., Xu, J-F., Rusu, D., Toma, C. & van Boven, J. F. M., 1-Feb-2019, In : European Journal of Internal Medicine. p. 54-70 60.

Development of the International Severe Asthma Registry (ISAR): A modified Delphi study

Bulathsinhala, L., Eleangovan, N., Heaney, L. G., Menzies-Gow, A., Gibson, P. G., Peters, M., Hew, M., van Boven, J. F., Lehtimäki, L., van Ganse, E., Belhassen, M., Harvey, E., Perez de Llano, L., Maitland-van der Zee, A. H., Papadopoulos, N., FitzGerald, J. M., Porsbjerg, C., Canonica, G. W., Backer, V., Rhee, C. K., Verhamme, K., Buhl, R., Cosio, B. G., Carter, V., Price, C., Le, T., Stagno d'Alcontres, M., Gopalan, G., Tran, T. & Price, D., 1-Feb-2019, In : Journal of Allergy and Clinical Immunology: In Practice. 7, 2, p. 578-588 13 p.

High COPD prevalence at high altitude: does household air pollution play a role?

Brakema, E. A., Tabyshova, A., Kasteleyn, M. J., Molendijk, E., van der Kleij, R. M. J. J., van Boven, J. F. M., Emilov, B., Akmatalieva, M., Mademilov, M., Numans, M. E., Williams, S., Sooronbaev, T. & Chavannes, N. H., 1-Feb-2019, In : European Respiratory Journal. 53, 2, 10 p., 1801193.

Voorzetkamers zijn niet één-op-één uitwisselbaar

Dekhuijzen, P. N. R., Van Aalderen, W. M. C., Kievits, R. M. M., Kooistra, J., Hagedoorn, P. & Van Boven, J. F. M., 25-Jan-2019, In : Pharmaceutisch Weekblad. 154, 4, p. 10-13 4 p.

ACO: Time to move from the description of different phenotypes to the treatable traits

Toledo-Pons, N., van Boven, J. F. M., Román-Rodríguez, M., Pérez, N., Valera Felices, J. L., Soriano, J. B. & Cosío, B. G., 24-Jan-2019, In : PLoS ONE. 14, 1, 15 p., e0210915.

Predicting Short-term and Long-term HbA1c Response after Insulin Initiation in Patients with Type 2 Diabetes Mellitus using Machine Learning

Nagaraj, S. B., Sidorenkov, G., van Boven, J. F. M. & Denig, P., 2019, In : Diabetes obesity & metabolism. 21, p. 2704-2711 8 p.

Global Alliance for Chronic Disease researchers' statement on multimorbidity

GACD Multi-Morbidity Working Group, Hurst, J. R., Dickhaus, J., Maulik, P. K., Miranda, J. J., Pastakia, S. D., Soriano, J. B., Siddharthan, T. & Vedanthan, R., 1-Dec-2018, In : The Lancet Global Health. 6, 12, p. 1270-1271 2 p.

Development of a cost-effectiveness model to assess asthma inhaler adherence and technique interventions

Kim, C., Dilokthornsakul, P., Campbell, J. D. & Van Boven, J. F. M., 1-Nov-2018, In : Respirology. 23, p. 211 1 p.

Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK

Voorham, J., Roche, N., Benhaddi, H., van der Tol, M., Carter, V., van Boven, J. F. M., Bjermer, L., Miravitlles, M. & Price, D. B., 27-Oct-2018, In : BMJ Open. 8, 10, 12 p., e022051.

Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

GBD 2016 Alcohol Collaborators, Griswold, M. G., Fullman, N., Hawley, C., Arian, N., Zimsen, S. R. M., Tymeson, H. D., Venkateswaran, V., Tapp, A. D., Forouzanfar, M. H., Salama, J. S., Abate, K. H., Abate, D., Abay, S. M., Abbafati, C., Abdulkader, R. S., Abebe, Z., Aboyans, V., Abrar, M. M., Acharya, P., Adetokunboh, O. O., Adhikari, T. B., Adsuar, J. C., Afarideh, M., Agardh, E. E., Agarwal, G., Aghayan, S. A., Agrawal, S., Ahmed, M. B., Akibu, M., Akinyemiju, T., Akseer, N., Al Asfoor, D. H., Al-Aly, Z., Alahdab, F., Alam, K., Albujeer, A., Alene, K. A., Ali, R., Ali, S. D., Alijanzadeh, M., Aljunid, S. M., Alkerwi, A., Allebeck, P., Alvis-Guzman, N., Amare, A. T., Aminde, L. N., Ammar, W., Leigh, J., Postma, M. J. & Van Boven, J. F. M., 22-Sep-2018, In : LANCET. 392, 10152, p. 1015-1035 21 p.

The silent socioeconomic impact of COPD/asthma in Africa, Asia and Europe - a FRESH AIR study

Brakema, E., Tabyshova, A., Van der Kleij, R., Sooronbaev, T., Lionis, C., Anastasaki, M., Pham Le An, T., Nguyen Than Luan, Kirenga, B., Walusimbi, S., Postma, M., Chavannes, N. & Van Boven, J., 15-Sep-2018, In : European Respiratory Journal. 52, 2 p.

Why prescribe ICS to Dutch COPD patients in primary care, and when and how to stop. Data from focus groups with patients and health care providers

De Jong, C., Van Boven, J., Schermer, T., Riemersma, R., Brill, E., Van Den Berge, M., Van Der Molen, T. & Kocks, J., 15-Sep-2018, In : European Respiratory Journal. 52, 2 p.

The impact of asthma and/or COPD on work absence

Dierick, B., De Blok, B. F., Van Der Molen, T., Toledo-Pons, N., Roman-Rodriguez, M., Cosio, B. G., Soriano, J. B., Kocks, J. W. H. & Van Boven, J. F. M., Sep-2018.

Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients

GLIMP Study Group, 1-Aug-2018, In : European Respiratory Journal. 52, 2, 14 p.

The burden of disease in Greece, health loss, risk factors, and health financing, 2000–16: an analysis of the Global Burden of Disease Study 2016

Tyrovolas, S., Kassebaum, N. J., Stergachis, A., Abraha, H. N., Alla, F., Androudi, S., Car, M., Chrepa, V., Fullman, N., Fürst, T., Haro, J. M., Hay, S. I., Jakovljevic, M. B., Jonas, J. B., Khalil, I. A., Kopec, J. A., Manguerra, H., Martopullo, I., Mokdad, A., Monasta, L., Nichols, E., Olsen, H. E., Rawaf, S., Reiner, R., Renzaho, A. M. N., Ronfani, L., Sanchez-Niño, M. D., Sartorius, B., Silveira, D. G. A., Stathopoulou, V., Stein Vollset, E., Stroumpoulis, K., Sawhney, M., Topor-Madry, R., Topouzis, F., Tortajada-Girbés, M., Tsilimbaris, M., Tsilimparis, N., Valsamidis, D., van Boven, J. F. M., Violante, F. S., Werdecker, A., Westerman, R., Whiteford, H. A., Wolfe, C. D. A., Younis, M. Z. & Kotsakis, G. A., 1-Aug-2018, In : The Lancet Public Health. 3, 8, p. 395-406 12 p.

Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations

McQueen, R. B., Sheehan, D. N., Whittington, M. D., van Boven, J. F. M. & Campbell, J. D., Aug-2018, In : Pharmacoeconomics. 36, 8, p. 957-971 15 p.

HbA1c response after insulin initiation in patients with type 2 diabetes mellitus in real life practice: Identifying distinct subgroups

Sidorenkov, G., van Boven, J. F. M., Hoekstra, T., Nijpels, G., Hoogenberg, K. & Denig, P., Aug-2018, In : Diabetes obesity & metabolism. 20, 8, p. 1957-1964 8 p.

Personalising adherence-enhancing interventions using a smart inhaler in patients with COPD: An exploratory cost-effectiveness analysis

van Boven, J. F. M., Cushen, B., Sulaiman, I., Greene, G., MacHale, E., Mokoka, M. C., Doyle, F., Reilly, R. B., Bennett, K. & Costello, R. W., 27-Jun-2018, In : npj Primary Care Respiratory Medicine. 28, 1, 3 p., 24.

The Clinical Impact of Different Adherence Behaviours in Patients with Severe COPD

Cushen, B., Sulaiman, I., Greene, G., MacHale, E., Mokoka, M., Reilly, R. B., Bennett, K., Doyle, F., van Boven, J. F. & Costello, R. W., 15-Jun-2018, In : American Journal of Respiratory and Critical Care Medicine. 197, 12, p. 1630-1633 3 p.

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016

GBD 2016 Healthcare Access and Quality Collaborators, 2-Jun-2018, In : The Lancet. 391, 10136, p. 2236-2271 36 p.

Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here?

Dekhuijzen, R., Lavorini, F., Usmani, O. S. & van Boven, J. F. M., 1-May-2018, In : Journal of Allergy and Clinical Immunology: In Practice. 6, 3, p. 785-793 9 p.

Diabetes mellitus and chronic kidney disease in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study

Moradi-Lakeh, M., El Bcheraoui, C., Khalil, I., Charara, R., Afshin, A., Wang, H., Collison, M., Krohn, K. J., Chew, A., Daoud, F., Blosser, C. D., Cornaby, L., Foreman, K. J., Kassebaum, N. J., Kemmer, L., Kutz, M., Liu, P., Zipkin, B., Ärnlöv, J., Abate, K. H., Ahmadi, A., Ahmadieh, H., Ahmed, M. B., Al-Aly, Z., Alam, K., Alasfoor, D., Ali, R., Alizadeh-Navaei, R., Alkaabi, J. M., Alkerwi, A., Al-Raddadi, R., Altirkawi, K. A., Alvis-Guzman, N., Amini, E., Anber, N., Anwari, P., Asgedom, S. W., Atey, T. M., Avila-Burgos, L., Awasthi, A., Azzopardi, P., Bärnighausen, T., Bacha, U., Barac, A., Bazargan-Hejazi, S., Bedi, N., Berhe, D. F., Beyene, A. S., Birhanu, M. M., van Boven, J. F. M. & Gbd 2015 Eastern Mediterranean Region Diabetes And Ckd Collaborators, May-2018, In : International Journal of Public Health. 63, Supplement 1, p. 177-186 10 p.

Availability, use, and affordability of medicines in urban China under universal health coverage: An empirical study in Hangzhou and Baoji

Huang, Y., Jiang, Y., Zhang, L., Mao, W., van Boven, J. F. M., Postma, M. J. & Chen, W., 27-Mar-2018, In : BMC Health Services Research. 18, 1, 10 p., 218.

Asthma Cost-Effectiveness Analyses: Are We Using the Recommended Outcomes in Estimating Value?

Kim, C. H., Dilokthornsakul, P., Campbell, J. D. & van Boven, J. F. M., 2018, In : Journal of Allergy and Clinical Immunology: In Practice. 6, 2, p. 619-632 14 p.

Deimplementation of ICS use in COPD patients in primary care, barriers and facilitators

de Jong, C., van Boven, J., Schermer, T. R. J., Riemersma, R., Brill, E., van den Berge, M., van der Molen, T. & Kocks, J. W. H., 2018.

Reasons to start and stop ICS in COPD

de Jong, C., van Boven, J., Schermer, T. R. J., Riemersma, R., Brill, E., van den Berge, M., van der Molen, T. & Kocks, J. W. H., 2018.

Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population

Bjermer, L., van Boven, J. F. M., Costa-Scharplatz, M., Keininger, D. L., Gutzwiller, F. S., Lisspers, K., Mahon, R., Olsson, P. & Roche, N., 11-Dec-2017, In : Respiratory Research. 18, 10 p., 206.

Relationship of inhaler adherence behaviour to clinical outcomes in copd: an observational study

Cushen, B., Greene, G., Sulaiman, I., Bennett, K., MacHale, E., Mokoka, M. C., van Boven, J. F. & Costello, R. W., 1-Nov-2017, In : Thorax. 72, Suppl 3, A228.

CHANGING ICS/LABA THERAPY FROM DPI TO PMDI: AN OBSERVATIONAL STUDY ON ASTHMA COST OUTCOMES IN SOUTH KOREA

Rhee, C. K., Park, H. Y., Yoo, K. H., Kim, D. K., Park, H-S., Ming, S. W. Y., van Boven, J., Ling, J. Z. J. & Price, D., Nov-2017, In : Respirology. 22, p. 96 1 p.

Costs of clinical events in diabetes type 2 patients in The Netherlands: A systematic review

Van Schoonhoven, A., De Vries, M., Gout-Zwart, J., Vemer, P., Van Boven, J., Dvortsin, E. & Postma, M. J., 1-Oct-2017, In : Value in Health. 20, 9, p. 485-486 2 p.

Real-world cost effectiveness comparison of symbicort turbuhaler and duoresp spiromax in UK patients with asthma or chronic obstructive pulmonary disease

Van Boven, J., Benhaddi, H., Roche, N., Bjermer, L., Miravitlles, M., Voorham, J. & Price, D., 1-Oct-2017, In : Value in Health. 20, 9, p. 645 1 p.

Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016

GBD 2016 Causes of Death Collaborators, 16-Sep-2017, In : The Lancet. 390, 10100, p. 1151-1210 60 p.

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Gakidou, E., Afshin, A., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Aboyans, V., Abu-Raddad, L. J., Abu-Rmeileh, N. M. E., Abyu, G. Y., Adedeji, I. A., Adetokunboh, O., Afarideh, M., Agrawal, A., Agrawal, S., Kiadaliri, A. A., Ahmadieh, H., Ahmed, M. B., Aichour, A. N., Aichour, I., Aichour, M. T. E., Akinyemi, R. O., Akseer, N., Alahdab, F., Al-Aly, Z., Alam, K., Alam, N., Alam, T., Alasfoor, D., Alene, K. A., Ali, K., Alizadeh-Navaei, R., Alkerwi, A., Alla, F., Allebeck, P., Al-Raddadi, R., Alsharif, U., Altirkawi, K. A., Alvis-Guzman, N., Amare, A. T., Amini, E., Ammar, W., Amoako, Y. A., Ansari, H., Berhe, D. F., Hoek, H. W., van Boven, J. F. M. & GBD Risk Factors Collaborators, 16-Sep-2017, In : The Lancet. 390, 10100, p. 1345-1422 78 p.

Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Hay, S. I., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulle, A. M., Abebo, T. A., Abera, S. F., Aboyans, V., Abu-Raddad, L. J., Ackerman, I. N., Adedeji, I. A., Adetokunboh, O., Afshin, A., Aggarwal, R., Agrawal, S., Agrawal, A., Kiadaliri, A. A., Ahmed, M. B., Aichour, A. N., Aichour, I., Aichour, M. T. E., Aiyar, S., Akinyemiju, T. F., Akseer, N., Al Lami, F. H., Alahdab, F., Al-Aly, Z., Alam, K., Alam, N., Alam, T., Alasfoor, D., Alene, K. A., Ali, R., Alizadeh-Navaei, R., Alkaabi, J. M., Alkerwi, A., Alla, F., Allebeck, P., Allen, C., Al-Maskari, F., AlMazroa, M. A., Al-Raddadi, R., Alsharif, U., Amare, A. T., Berhe, D. F., Hoek, H. W., Liu, Y., van Boven, J. F. M. & GBD 2016 DALYs HALE Collaborators, 16-Sep-2017, In : The Lancet. 390, 10100, p. 1260-1344 85 p.

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

GBD 2016 Dis Injury Incidence Prev, 16-Sep-2017, In : The Lancet. 390, 10100, p. 1211-1259 49 p.

Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016

GBD 2016 Mortality Collaborators, 16-Sep-2017, In : The Lancet. 390, 10100, p. 1084-1150 67 p.

Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: An analysis from the Global Burden of Disease Study 2016

Fullman, N., Barber, R. M., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Aboyans, V., Abu-Raddad, L. J., Abu-Rmeileh, N. M. E., Adedeji, I. A., Adetokunboh, O., Afshin, A., Agrawal, A., Agrawal, S., Kiadaliri, A. A., Ahmadieh, H., Ahmed, M. B., Aichour, A. N., Aichour, I., Aichour, M. T. E., Aiyar, S., Akinyemi, R. O., Akseer, N., Al-Aly, Z., Alam, K., Alam, N., Alasfoor, D., Alene, K. A., Alizadeh-Navaei, R., Alkerwi, A., Alla, F., Allebeck, P., Allen, C., Al-Raddadi, R., Alsharif, U., Altirkawi, K. A., Alvis-Guzman, N., Amare, A. T., Amini, E., Ammar, W., Antonio, C. A. T., Ansari, H., Anwari, P., Arora, M., Berhe, D. F., Hoek, H. W., van Boven, J. F. M. & GBD 2016 SDG Collaborators, 16-Sep-2017, In : The Lancet. 390, 10100, p. 1423-1459 37 p.

Asthma cost-effectiveness analyses: Are we using the recommended outcomes in estimating value?

Dilokthornsakul, P., Campbell, J. D., van Boven, J. F. M. & Kim, C. H., 1-Sep-2017, In : European Respiratory Journal. 50, 61, 1 p.

Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015: a systematic analysis for the Global Burden of Disease Study 2015

Soriano, J. B., Abajobir, A. A., Abate, K. H., Abera, S. F., Agrawal, A., Ahmed, M. B., Aichour, A. N., Aichour, I., Aichour, M. T. E., Alam, K., Alam, N., Alkaabi, J. M., Al-Maskari, F., Alvis-Guzman, N., Amberbir, A., Amoako, Y. A., Ansha, M. G., Anto, J. M., Asayesh, H., Atey, T. M., Avokpaho, E. F. G. A., Barac, A., Basu, S., Bedi, N., Bensenor, I. M., Berhane, A., Beyene, A. S., Bhutta, Z. A., Biryukov, S., Boneya, D. J., Brauer, M., Carpenter, D. O., Casey, D., Christopher, D. J., Dandona, L., Dandona, R., Dharmaratne, S. D., Huyen Phuc Do, Fischer, F., Geleto, A., Ghoshal, A. G., Gillum, R. F., Ginawi, I. A. M., Gupta, V., Hay, S. I., Hedayati, M. T., Horita, N., Hosgood, H. D., Jakovljevic, M. M. B., van Boven, J. F. M. & GBD 2015 Chronic Resp Dis Collabor, 1-Sep-2017, In : The Lancet. Respiratory Medicine. 5, 9, p. 691-706 16 p.

Indacaterol/glycopyrronium (IND/GLY) is cost-effective compared with salmeterol/fluticasone (SFC) in Swedish chronic obstructive pulmonary disease (COPD) patients

Bjermer, L., van Boven, J. F. M., Costa-Scharplatz, M., Gutzwiller, F. S., Lisspers, K., Mahon, R., van der Molen, T., Olsson, P., Roche, N. & Burke, C., 1-Sep-2017, In : European Respiratory Journal. 50, 1 p.

Late Breaking Abstract - Health economic burden of asthma/COPD in Uganda, Vietnam, Kyrgyzstan and Greece: FRESH AIR results

van Boven, J. F. M., Brakema, E. A., Walusimbi, S., Anastasaki, M., Tabyshova, A., Luan Nguyen, Lionis, C., Tsiligianni, I. A., Kirenga, B. J., An, P. L., Sooronbaev, T., Postma, M. J. & Chavannes, N. H., 1-Sep-2017, In : European Respiratory Journal. 50, 1 p.

Real-life evaluation of budesonide/formoterol (DuoResp Spiromax) for the management of asthma and COPD in the UK

Roche, N., Benhaddi, H., van der Tol, M., Chambers, J., van Boven, J. F. M., Bjermer, L., Miravitlles, M., Price, D. & Voorham, J., 1-Sep-2017, In : European Respiratory Journal. 50, 1 p.

Electric scooters: Batteries in the battle against ambient air pollution?

van Boven, J. FM., An, P. L., Kirenga, B. J. & Chavannes, N. H., 4-Aug-2017, In : The Lancet Planetary Health. 1, 5, 2 p.

Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015

van Boven, J. & GBD 2015 Healthcare Access and Quality Collaborators, 15-Jul-2017, In : The Lancet. 390, 10091, p. 231-266 36 p.

Costly comorbidities of COPD: The ignored side of the coin?

van Boven, J. F. M., 1-Jul-2017, In : European Respiratory Journal. 50, 3 p., 1700917.

In patients with severe uncontrolled asthma, does knowledge of adherence and inhaler technique using electronic monitoring improve clinical decision making?: A protocol for a randomised controlled trial

Mokoka, M. C., Lombard, L., MacHale, E., Walsh, J., Cushen, B., Sulaiman, I., Mc Carthy, D., Boland, F., Doyle, F., Hunt, E., Murphy, D. M., Faul, J., Butler, M., Hetherington, K., Fitzgerald, J. M., van Boven, J. FM., Heaney, L. G., Reilly, R. & Costello, R. W., Jun-2017, In : BMJ Open. 7, 6, 10 p., e015367.

Clinical characteristics, treatment patterns, and socio-economic burden of COPD in Bulgaria

Kamusheva, M., Dimitrova, M., van Boven, J. F. M., Postma, M. J., van der Molen, T., Kocks, J. W. H., Mitov, K., Doneva, M., Petrova, D., Georgiev, O., Petkova, V. & Petrova, G., May-2017, In : Journal of Medical Economics. 20, 5, p. 503-509 7 p.

Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: A report from the First European Congress on Adherence to Therapy

van Boven, J. F. M., Lavorini, F., Dekhuijzen, P. N. R., Blasi, F., Price, D. B. & Viegi, G., May-2017, In : European Respiratory Journal. 49, 5, 5 p.

Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study

Voorham, J., Vrijens, B., van Boven, J. FM., Ryan, D., Miravitlles, M., Law, L. M. & Price, D. B., 18-Apr-2017, In : Pragmatic and Observational Research. 8, p. 31-41 11 p.

Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review

Klijn, S. L., Hiligsmann, M., Evers, S. M. A. A., Román-Rodríguez, M., van der Molen, T. & van Boven, J. F. M., 13-Apr-2017, In : npj Primary Care Respiratory Medicine. 27, 1, 10 p., 24.

Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD

Westerik, J. A. M., Metting, E. I., van Boven, J. F. M., Tiersma, W., Kocks, J. W. H. & Schermer, T. R. J., 6-Feb-2017, In : Respiratory Research. 18, 31, 17 p.

Optimizing identification and management of COPD patients - reviewing the role of the community pharmacist

van der Molen, T., van Boven, J. F. M., Maguire, T., Goyal, P. & Altman, P., Jan-2017, In : British Journal of Clinical Pharmacology. 83, 1, p. 192-201 10 p.

Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations

van der Schans, S., Goossens, L. M. A., Boland, M. R. S., Kocks, J. W. H., Postma, M. J., van Boven, J. F. M. & Rutten-van Molken, M. P. M. H., Jan-2017, In : Pharmacoeconomics. 35, 1, p. 43-63 21 p.

De-implementing inappropriate inhaled corticosteroids use in Dutch COPD patients in primary care: perceived facilitators and barriers from focus groups in patients and health care providers.

Kocks, J. W. H., de Jong, C., Schermer, T. R. J., Riemersma, R., Brill, E., van den Berge, M., van der Molen, T. & van Boven, J., 2017.

Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study

GLIMP Investigators, 1-Dec-2016, In : Lancet Infectious Diseases. 16, 12, p. 1364-1376 13 p.

The burden of COPD across the European Union: development of the European COPD Atlas

van Boven, J. FM., Gaughan, J., Soriano, J. B., de Sousa, J. C., Baxter, N., Román Rodriguez, M., Vilaro, J., Williams, S., Fitch, S., Kishore, K. & Chaudhury, H., 1-Dec-2016, In : Thorax. 71, S3, P139.

Cost comparison of asthma treatments in 12-week study: Caution about matching and short observational follow-up

Price, D. B., van Boven, J. F. M., Law, L. M., Cifra, A. & McQueen, R. B., 2-Nov-2016, In : Multidisciplinary respiratory medicine. 11, 5 p., 39.

COPD medication adherence and quality of life

Boland, M. R. S., van Boven, J. FM., Kruis, A. L., Chavannes, N. H., van der Molen, T., Goossens, L. M. A. & Rutten-van Mölken, M. P. M. H., 1-Nov-2016, In : European Respiratory Journal. 48, S60, PA3961.

Current burden of uncontrolled asthma in the general population: The OPCRD asthma state of the union study

Tan, S., Thomas, M., Nibber, A., van Aalderen, W. M. C., Bleecker, E. R., Campbell, J. D., Roche, N., Haughney, J., Van Ganse, E., Park, H. Y., Rhee, C-K., Skinner, D., Chisholm, A., van Boven, J. FM., Bonomally, R., Thomas, V., Soriano, J. B. & Price, D., 1-Nov-2016, In : European Respiratory Journal. 48, S60, PA4591.

Educational inhaler technique interventions in asthma & COPD patients: A systematic review

Klijn, S., Hiligsmann, M., Evers, S., Román Rodriguez, M., van der Molen, T. & van Boven, J. FM., 1-Nov-2016, In : European Respiratory Journal. 48, S60, OA1998.

Impact of chronic comorbidity on the occurrence of exacerbations in primary care patients with COPD: preliminary results from a real-life cohort database study

Westerik, J. A. M., Metting, E., van Boven, J. FM., Tiersma, W., Kocks, J. W. H. & Schermer, T. R. J., 1-Nov-2016, In : European Respiratory Journal. 48, S60, PA871.

Real-life characteristics of asthma inhaler device use in South Korea

Wan Yau Ming, S., Rhee, C. K., Park, H. Y., Yoo, K. H., Kim, D. K., Van Boven, J. F., Price, D. & Park, H. S., 1-Nov-2016, In : Respirology. 21, p. 170 1 p., APSR6-0779.

Real-life effects of switching LABA/ICS dry powder inhalers to formoterol/fluticasone in Korean asthma patients: The Transfform study

Price, D., Park, H. S., Yoon, D., Lee, H. Y., Wan Yau Ming, S. & Van Boven, J. F., 1-Nov-2016, In : Respirology. 21, p. 22 1 p.

Cost-effectiveness analyses of pharmacologic maintenance treatment for chronic obstructive pulmonary disease: A systematic review

Van Der Schans, S., Goossens, L. M., Boland, M. R., Kocks, J., Postma, M. J., Van Boven, J. F. & Rutten-van Mölken, M. P., Nov-2016, In : Value in Health. 19, 7, p. A556 1 p.

Hollywood raising awareness of smoking-related diseases: can it proactively counteract the impact of smoking in movies?-the final mission of Star Trek's Mr Spock

van Boven, J. F. M. & Kaplan, A. G., 20-Oct-2016, In : npj Primary Care Respiratory Medicine. 26, 2 p., 16052.

COPD case finding: Effective, but also cost-effective?

van Boven, J. F., McQueen, R. B. & Price, D. B., 1-Oct-2016, In : The Lancet. Respiratory Medicine. 4, 10, p. e49 1 p.

Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands

van Boven, J. F., Kocks, J. W. & Postma, M. J., 1-Oct-2016, In : International Journal of Chronic Obstructive Pulmonary Disease. 11, 1, p. 2191-2201 11 p.

Current burden of uncontrolled asthma in the general population: The OPCRD asthma state of the Union study

Nibber, A., Thomas, M., Thomas, V., Van Aalderen, W., Bleecker, E., Campbell, J., Roche, N., Haughney, J., Van Ganse, E., Park, H-Y., Rhee, C. K., Skinner, D., Chisholm, A., Van Boven, J. F. M., Soriano, J. B. & Price, D., 1-Jul-2016, In : Journal of thoracic disease. 8

Opportunities for real-life respiratory research in Korea: The HIRA database and beyond

Van Boven, J. F. M., Rhee, C-K., Park, H-Y., Yoo, K. H., Kim, D-K., Soriano, J., Ming, S. W. Y., Price, D. & Park, H. S., 1-Jul-2016, In : Journal of thoracic disease. 8, Supplement 5, AB032.

Comorbidome, pattern and impact of asthma-COPD overlap syndrome (ACOS) in real-life

van Boven, J. F. M., Roman-Rodriguez, M., Palmer, J. F., Toledo-Pons, N., Cosio, B. G. & Soriano, J. B., Apr-2016, In : Chest. 149, 4, p. 1011-1020 10 p.

Enhancing the use of Asthma and COPD Assessment Tools in Balearic Primary Care (ACATIB): a region-wide cluster-controlled implementation trial

Román-Rodríguez, M., Pardo, M. G., López, L. G., Ruiz, A. U. & van Boven, J. F., 11-Mar-2016, In : npj Primary Care Respiratory Medicine. 26, 6 p., 16003.

Effects of targeting disease and medication management interventions towards patients with COPD

van Boven, J. F. M., Stuurman-Bieze, A. G. G., Hiddink, E. G. & Postma, M. J., Feb-2016, In : Current Medical Research and Opinion. 32, 2, p. 229-239 11 p., UNSP ST-0434.R1/1110129.

Increasing research capacity and awareness of chronic lung diseases in East Africa

Kirenga, B., Sewankambo, N. K., van Gemert, F., van Boven, J. & van der Molen, T., 22-Jan-2016

Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature

Berm, E. J. J., Looff, M. D., Wilffert, B., Boersma, C., Annemans, L., Vegter, S., van Boven, J. FM. & Postma, M. J., 11-Jan-2016, In : PLoS ONE. 11, 1, 22 p., e0146262.

Higher Adherence During Reimbursement of Pharmacological Smoking Cessation Treatments

van Boven, J. F. M. & Vemer, P., Jan-2016, In : Nicotine and Tobacco Research. 18, 1, p. 56-63 8 p.

Investigating the association between medication adherence and health-related quality of life in COPD: Methodological challenges when using a proxy measure of adherence

Boland, M. R. S., van Boven, J. F. M., Kruis, A. L., Chavannes, N. H., van der Molen, T., Goossens, L. M. A. & Rutten-van Molken, M. P. M. H., Jan-2016, In : Respiratory Medicine. 110, p. 34-45 12 p.

Enhancing Respiratory Medication Adherence: The Role of Health Care Professionals and Cost-Effectiveness Considerations

van Boven, J. F. M., Ryan, D., Eakin, M. N., Canonica, G. W., Barot, A., Foster, J. M. & Resp Effectiveness Grp, 2016, In : Journal of Allergy and Clinical Immunology: In Practice. 4, 5, p. 835-846 12 p.

What We Mean When We Talk About Adherence in Respiratory Medicine

Vrijens, B., Dima, A. L., Van Ganse, E., van Boven, J. F. M., Eakin, M. N., Foster, J. M., de Bruin, M., Chisholm, A. & Price, D., 2016, In : Journal of Allergy and Clinical Immunology: In Practice. 4, 5, p. 802-812 11 p.

LATE-BREAKING ABSTRACT: Prevalence of comorbidities in patients with asthma-COPD overlap syndrome (ACOS) in primary care

van Boven, J. FM., Roman-Rodriguez, M., Palmer, J. F., Toledo Pons, N., Cosío, B. G. & Soriano, J. B., 1-Sep-2015, In : European Respiratory Journal. 46, 59, 4786.

Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol

van Boven, J. F. M., Roman-Rodriguez, M., Kocks, J. W. H., Soriano, J. B., Postma, M. J. & van der Molen, T., 6-Aug-2015, In : npj Primary Care Respiratory Medicine. 25, 4 p., 15051.

Towards tailored and targeted adherence assessment to optimise asthma management

van Boven, J. F. M., Trappenburg, J. C. A., van der Molen, T. & Chavannes, N. H., 16-Jul-2015, In : npj Primary Care Respiratory Medicine. 25, 6 p., 15046.

Mapping the Clinical Chronic Obstructive Pulmonary Disease Questionnaire onto Generic Preference-Based EQ-5D Values

Boland, M. R. S., van Boven, J. F. M., Kocks, J. W. H., van der Molen, T., Goossens, L. M., Chavannes, N. H. & Rutten-van Molken, M. P. M. H., Mar-2015, In : Value in Health. 18, 2, p. 299-307 9 p.

Enhancing adherence in patients with COPD: Targets, interventions & cost-effectiveness

van Boven, J. F. M., 2015, [Groningen]: University of Groningen. 230 p.

Sustainable policy: Higher medication use & adherence during reimbursement of pharmacologic smoking cessation treatments

Van Boven, J. F. & Vemer, P., 1-Nov-2014, In : Value in Health. 17, 7, p. 603 1 p.

Impact of multiple-dose versus single-dose inhaler devices on COPD patients' persistence with long-acting beta(2)-agonists: A dispensing database analysis

van Boven, J. F. M., van Raaij, J. J., van der Galiën, R., Postma, M. J., van der Molen, T., Dekhuijzen, P. N. R. & Vegter, S., 2-Oct-2014, In : npj Primary Care Respiratory Medicine. 24, 6 p., 14069.

Therapietrouwbevordering COPD bespaart kosten

Van Boven, J., Tommelein, E., Mehuys, E., Boussery, K., Vegter, S., Brusselle, G., Rutten-Van Mölken, M. & Postma, M., 26-Sep-2014, In : Pharmaceutisch Weekblad. 149, 39, p. 20-21 2 p.

Optimalisation de la pharmacothérapie en pharmacie d'officine chez des patients atteints de Bronchopneumopathie Chronique Obstructive (BPCO): une analyse coût-efficacité

van Boven, J. F., Tommelein, E., Boussery, K., Mehuys, E., Vegter, S., Brusselle, G. G., Rutten-van Mölken, M. P. & Postma, M. J., 1-Sep-2014, In : Journal de Pharmacie de Belgique. 3, p. 15-16 2 p.

Therapietrouwbevordering lipidenverlagers is kosteneffectief: Kosteneffectiviteit bij primaire, kostenbesparing bij secundaire preventie

Vegter, S., Oosterhof, P., Van Boven, J. F. M., Stuurman-Bieze, A. G. G., Hiddink, E. & Postma, M. J., 29-Aug-2014, In : Pharmaceutisch Weekblad. 149, 35, p. 30-31 2 p.

Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence

van Boven, J. F. M., Stuurman-Bieze, A. G. G., Hiddink, E. G., Postma, M. J. & Vegter, S., Aug-2014, In : Journal of Managed Care Pharmacy. 20, 8, p. 786-792 7 p.

Improving adherence to lipid-lowering therapy in a community pharmacy intervention program: a cost-effectiveness analysis

Vegter, S., Oosterhof, P., van Boven, J. F. M., Stuurman-Bieze, A. G. G., Hiddink, E. G. & Postma, M. J., Jul-2014, In : Journal of Managed Care Pharmacy. 20, 7, p. 722-732 11 p.

Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: A cost-effectiveness analysis

van Boven, J. F. M., Tommelein, E., Boussery, K., Mehuys, E., Vegter, S., Brusselle, G. G. O., Rutten-van Molken, M. P. M. H. & Postma, M. J., 14-Jun-2014, In : Respiratory Research. 15, 1, 10 p., 66.

Proactive pharmaceutical care interventions decrease patients' nonadherence to osteoporosis medication

Stuurman-Bieze, A. G. G., Hiddink, E. G., van Boven, J. F. M. & Vegter, S., Jun-2014, In : Osteoporosis International. 25, 6, p. 1807-1812 6 p.

Cost-effectiveness analysis of a pharmacist-led intervention on improving inhaler adherence in patients with chronic obstructive pulmonary disease

Van Boven, J. F., Tommelein, E., Boussery, K., Mehuys, E., Vegter, S., Brusselle, G. G., Rutten-Van Mölken, M. P. M. H. & Postma, M. J., 1-May-2014, In : Value in Health. 17, 3, p. A136 1 p.

Economic Evaluation of Ropinirole Prolonged Release for Treatment of Parkinson’s Disease in The Netherlands

van Boven, J. F. M., Novak, A., Driessen, M. T., Boersma, C., Boomsma, M. M. & Postma, M. J., Mar-2014, In : Drugs & Aging. 31, 3, p. 193-201 9 p.

Clinical and economic impact of non-adherence in COPD: A systematic review

van Boven, J. F. M., Chavannes, N. H., van der Molen, T., Rutten-van Molken, M. P. M. H., Postma, M. J. & Vegter, S., Jan-2014, In : Respiratory Medicine. 108, 1, p. 103-113 11 p.

Gerichte farmaceutische zorg voor patiënten met astma en COPD: een oriënterende studie

van Boven, J. FM., Stuurman-Bieze, A. GG., Hiddink, E. G., Postma, M. J. & Vegter, S., 2014, In : Pharmaceutisch Weekblad Wetenschappelijk Platform. 149, 12, p. 49-53 8:A1413.

Het optimaliseren van de farmacotherapie bij patiënten met Chronisch Obstructief Longlijden (COPD) in de officina-apotheek: een kosten-effectiviteitsanalyse[1]

van Boven, J., Tommelein, E., Mehuys, E., Vegter, S., Brusselle, G. GO., Rutten-van Molken, M. P. M. H. & Postma, M., 2014, In : Farmaceutisch Tijdschrift voor België. 94, 3, p. 15-16

COPD in the working age population: The economic impact on both patients and government

Van Boven, J. F. M., Vegter, S., Van Der Molen, T. & Postma, M. J., 1-Dec-2013, In : COPD: Journal of Chronic Obstructive Pulmonary Disease. 10, 6, p. 629-639 11 p.

The pharmacists' potential to provide targets for interventions to optimize pharmacotherapy in patients with asthma

van Boven, J. F. M., Hiddink, E. G., Stuurman-Bieze, A. G. G., Schuiling-Veninga, N., Postma, M. & Vegter, S., Dec-2013, In : International Journal of Clinical Pharmacy. 35, 6, p. 1075-1082 8 p.

Cost-effectiveness of increasing statin adherence for primary and secondary prevention in community pharmacies

Vegter, S., Oosterhof, P., Van Boven, J. F., Stuurman-Bieze, A. G. G., Hiddink, E. G. & Postma, M. J., 1-Nov-2013, In : Value in Health. 16, 7, p. 528 1 p.

Proactive pharmaceutical care interventions improve patients' adherence to lipid-lowering medication

Stuurman-Bieze, A. G. G., Hiddink, E. G., van Boven, J. F. M. & Vegter, S., Nov-2013, In : Annals of Pharmacotherapy. 47, 11, p. 1448-1456 9 p.

Persistence with osteoporosis medication among newly-treated osteoporotic patients

van Boven, J. F. M., de Boer, P. T., Postma, M. J. & Vegter, S., Sep-2013, In : Journal of bone and mineral metabolism. 31, 5, p. 562-570 9 p.

Inhaled Corticosteroids and the Occurrence of Oral Candidiasis: A Prescription Sequence Symmetry Analysis

van Boven, J. F. M., de Jong-van den Berg, L. T. W. & Vegter, S., Apr-2013, In : Drug Safety. 36, 4, p. 231-236 6 p.

Economische uitkomsten

Vegter, S., van Boven, J., Hiddink, E. G. & Postma, M., 2013, Handboek farmaceutische patiëntenzorg: achtergronden en praktijk. de Gier, JJ., Bouvy, ML., Egberts, ACG. & de Smet, PAGM. (eds.). Vol. Hoofdstuk 21. p. 275-282

The economic impact of COPD in patients of working age: Results from 'COPD uncovered' the Netherlands

Van Boven, J. F., Van Der Molen, T., Postma, M. J. & Vegter, S., 1-Nov-2012, In : Value in Health. 15, 7, p. 562 1 p.

Cost-effectiveness of increasing bisphosphonates adherence for osteoporosis in community pharmacies

Van Boven, J. F. M., Oosterhof, P., Hiddink, E. G., Stuurman-Bieze, A. G. G., Postma, M. J. & Vegter, S., 1-Nov-2011, In : Value in Health. 14, 7, p. 310 1 p.

Gestructureerde medicatiebegeleiding om de therapietrouw bij bisfosfonaten te verbeteren biedt kansen voor kosteneffectieve farmaceutische patiëntenzorg

van Boven, J., Hiddink, E., Stuurman-Bieze, AGG., Postma, M. & Vegter, S., 2011, In : Pharmaceutische Weekblad Wetenschappelijk Platform. 5, p. 147-153 a1132.

Activities

Tailored and cost-effective COPD care: a global health perspective (LiveTalk for Johns Hopkins University, USA. Chronic Diseases in Low and Middle Income Countries: Prevalence and Epidemiology course 2020)

Job Boven, van (Lecturer)
6-Feb-2020

Socioeconomics and Health economics of allergic diseases (EAACI-PAAM 2019, Florence, Italy)

Job Boven, van (Invited speaker)
18-Oct-2019

ZonMW Goed Gebruik Geneesmiddelen (GGG) - Commissie (External organisation)

Job Boven, van (Member)
1-Oct-2019 → …

PhD assessment committee member at Universidade da Beira Interior, Portugal

Job Boven, van (Examiner)
23-Sep-2019

Real-world drug use and outcomes in respiratory diseases: From smart adherence monitoring to cost-effectiveness (Monash University seminar, Australia)

Job Boven, van (Invited speaker)
14-Aug-2019

Pragmatic and Observational Research (Journal)

Job Boven, van (Editorial board member)
1-May-2019 → …

Therapietrouw management 2.0: big data, smart inhalers & haar analyse (Longdagen 2019)

Job Boven, van (Invited speaker)
10-Apr-2019

Detection & management of poor adherence in severe asthma (Severe asthma preceptorship 2019, Melbourne, Australia)

Job Boven, van (Invited speaker)
28-Feb-2019

Health Research Council of New Zealand (External organisation)

Job Boven, van (Member)
15-Feb-2019

Monash Univ, Monash University, Monash Inst Pharmaceut Sci

Job Boven, van (Visiting researcher)
30-Dec-201817-Mar-2019

Economic evaluation to inform scale-up of chronic disease interventions (Global Alliance for Chronic Diseases annual meeting 2018, Sao Paulo, Brazil)

Job Boven, van (Invited speaker)
14-Nov-2018

How to address non-adherence with maintenance therapy in COPD? (Lung Forum, Kopenhagen, Denmark, 2018)

Job Boven, van (Invited speaker)
27-Oct-2018

Objective measurement of medication adherence (workshop at 34th ISPE, Prague, Czech Republic, 2018)

Job Boven, van (Invited speaker)
22-Aug-2018

Tuberculosis & Respiratory Diseases (Journal)

Job Boven, van (Editorial board member)
24-Mar-2018 → …

International Inhaler Research Workinggroup Conference 2018

Job Boven, van (Invited speaker)
16-Mar-2018

Models to estimate burden of respiratory diseases around the EU (EAACI health economics task force, Padua, Italy)

Job Boven, van (Speaker)
7-Dec-2017

EAACI Health Economics Task Force (Secretary) (External organisation)

Job Boven, van (Chair)
1-Dec-2017 → …

Clinical eHealth (Journal)

Job Boven, van (Editorial board member)
15-Nov-2017 → …

Royal Dutch Pharmacists Assoc KNMP (External organisation)

Job Boven, van (Member)
23-Oct-2017 → …

Euro-Asian Respiratory Society congress 2017 (Kyrgyzstan)

Job Boven, van (Speaker)
29-Sep-2017

International Primary Care Respiratory Group congress South East Asia

Job Boven, van (Chair)
3-Aug-20175-Aug-2017

Longdagen 2017

Job Boven, van (Keynote speaker)
12-Apr-2017

Univ Crete, University of Crete, Fac Med

Job Boven, van (Visiting researcher)
4-Apr-2017

Congresso de Pneumologia do Norte (Porto, Portugal)

Job Boven, van (Keynote/plenary speaker)
3-Mar-2017

COPD Modelling expert meeting

Job Boven, van (Keynote speaker)
3-Feb-2017

Global Burden of Disease (GBD) collaborator network (External organisation)

Job Boven, van (Member)
20-Jan-2017 → …

COPD & Astma Huisartsen Advies Groep (CAHAG) Congres

Job Boven, van (Invited speaker)
19-Jan-2017

Global Alliance for Chronic Diseases (GACD) (External organisation)

Job Boven, van (Member)
20-Dec-201620-Dec-2018

Winter meeting of the British Thoracic Society

Job Boven, van (Contributor)
8-Dec-2016

Refereeravond eerstelijn: Longziekten

Job Boven, van (Keynote speaker)
22-Nov-2016

European Congress on Adherence to Therapy

Job Boven, van (Keynote speaker)
18-Nov-2016

Ministry of Health Kyrgyzstan

Job Boven, van (Visiting researcher)
12-Oct-2016

Symposium van het Noorden

Job Boven, van (Keynote speaker)
4-Oct-2016

Health Economics

Job Boven, van (Invited speaker)
29-Sep-2016

Univ Med & Pharm Ho Chi Minh City, Hochiminh City University of Medicine & Pharmacy

Job Boven, van (Visiting researcher)
15-Jul-2016

American Thoracic Society International Congress 2016

Job Boven, van (Participant)
15-May-201617-May-2016

Respiratory Effectiveness Group

Job Boven, van (Keynote speaker)
15-Apr-2016

College ter Beoordeling van Geneesmiddelen (External organisation)

Job Boven, van (Member)
1-Mar-20161-Mar-2019

European COPD Coalition (ECC) (External organisation)

Job Boven, van (Member)
3-Jan-201631-Dec-2017

International Society For Pharmacoeconomics and Outcomes Research (External organisation)

Job Boven, van (Member)
20162018

Makerere Univ, Makerere University, Mulago Hosp

Job Boven, van (Visiting researcher)
18-Nov-2015

World Allergy Congress

Job Boven, van (Keynote speaker)
17-Oct-2015

Respiratory Effectiveness Group (Event)

Job Boven, van (Member)
8-Jun-20158-Jun-2018

Respiratory Effectiveness Group

Job Boven, van (Keynote speaker)
20-Apr-2015

Respiratory Effectiveness Group, Cambridge, UK. (External organisation)

Job Boven, van (Member)
20152018

International Society for Pharmacoeconomics and Outcomes Research 2014

Job Boven, van (Speaker)
3-Jun-2014

PRISMA symposium

Job Boven, van (Keynote speaker)
20-May-2013

ID: 323117